23 May 2013
Keywords: evt101, completes, ph, ad, study, says, evotec
Article | 14 August 2006
German drug discovery firm Evotec AG says that it has successfully completed a Phase I trial of EVT 101, its developmental ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 August 2006
7 August 2006
© 2013 thepharmaletter.com